Chapter 39
Malignant Liver Tumors in Children
Xavier Rogiers MD, PhD,
Ruth De Bruyne MD,
Xavier Rogiers MD, PhD
Department of General and Hepatobiliary, Surgery, Transplantation Center, University Medical Center Ghent, Ghent, Belgium
Search for more papers by this authorRuth De Bruyne MD
Department of Pediatrics, Section of Pediatric Gastroenterology, University Medical Center Ghent, Ghent, Belgium
Search for more papers by this authorXavier Rogiers MD, PhD,
Ruth De Bruyne MD,
Xavier Rogiers MD, PhD
Department of General and Hepatobiliary, Surgery, Transplantation Center, University Medical Center Ghent, Ghent, Belgium
Search for more papers by this authorRuth De Bruyne MD
Department of Pediatrics, Section of Pediatric Gastroenterology, University Medical Center Ghent, Ghent, Belgium
Search for more papers by this authorBook Editor(s):Pierre-Alain Clavien MD, Phd, FACS, FRCS,
Stefan Breitenstein MD,
Pierre-Alain Clavien MD, Phd, FACS, FRCS
Professor Chairman
Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland
Search for more papers by this authorStefan Breitenstein MD
Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland
Search for more papers by this authorFirst published: 09 December 2009
Summary
This chapter contains sections titled:
-
Hepatoblastoma
-
Angiosarcoma
-
Hepatocellular carcinoma
-
Other tumors
-
Metastatic lesions
-
Self-assessment questions
-
Undifferentiated (embryonal) sarcoma
-
Embryonal rhabdomyosarcoma
-
References
-
Self-assessment answers
References
- Darbari A, Sabin KM, Shapiro CN, et al. Epidemiology of primary hepatic malignancies in US children. Hepatology 2003; 38: 560–6.
- Mann JR, Kasthuri N, Raafat F, et al. Malignant hepatic tumors in children: incidence, clinical features and aetiology. Paediatr Perinat Epidemiol 1990; 4: 276–89.
- Pham TH, Iqbal CW, Grams JM, et al. Outcomes of primary liver cancer in children: an appraisal of experience. J Pediatr Surg 2007; 42: 834–9.
- Litten JB, Tomlinson GE. Liver tumors in children. Oncologist 2008; 13: 812–20.
- Finegold MJ, Egler RA, Goss JA, et al. Liver tumors: pediatric population. Liver Transpl 2008; 14: 1545–56.
- Stiller CA, Pritchard J, Steliarova-Foucher E. Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42: 2115–23.
- Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 2004; 364: 2097–105.
- DeBaun MR, Tucker MA. Risk of cancer during the fi rst four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998; 132: 398–400.
- Clericuzio CL, Chen E, McNeil DE, et al. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 2003; 143: 270–2.
- Tan TY, Amor DJ. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 2006; 42: 486–90.
-
Hoyme HE, Seaver LH, Jones KL, Procopio F, Crooks W, Feingold M. Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 1998; 79: 274–8.
10.1002/(SICI)1096-8628(19981002)79:4<274::AID-AJMG8>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- Gracia Bouthelier R, Lapunzina P. Follow-up and risk of tumors in overgrowth syndromes. J Pediatr Endocrinol Metab 2005; 18 (Suppl 1): 1227–35.
- Giardiello FM, Offerhaus GJ, Krush AJ, et al. Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 1991; 119: 766–8.
- Hughes LJ, Michels VV. Risk of hepatoblastoma in familial adenomatous polyposis. Am J Med Genet 1992; 43: 1023–5.
- Aretz S, Koch A, Uhlhaas S, et al. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 2006; 47: 811–18.
- Reynolds P, Urayama KY, Von Behren J, Feusner J. Birth characteristics and hepatoblastoma risk in young children. Cancer 2004; 100: 1070–6.
- Sorahan T, Lancashire RJ. Parental cigarette smoking and childhood risks of hepatoblastoma: OSCC data. Br J Cancer 2004; 90: 1016–18.
- Perilongo G, Shafford EA. Liver tumours. Eur J Cancer 1999; 35: 953–8; discussion 958–9.
- Galifer RB, Sultan C, Margueritte G, Barneon G. Testosteroneproducing hepatoblastoma in a 3-year-old boy with precocious puberty. J Pediatr Surg 1985; 20: 713–14.
-
Nakagawara A, Ikeda K, Tsuneyoshi M, et al. Hepatoblastoma producing both alpha-fetoprotein and human chorionic gonadotropin. Clinicopathologic analysis of four cases and a review of the literature. Cancer 1985; 56: 1636–42.
10.1002/1097-0142(19851001)56:7<1636::AID-CNCR2820560729>3.0.CO;2-R CAS PubMed Web of Science® Google Scholar
- Komura E, Matsumura T, Kato T, Tahara T, Tsunoda Y, Sawada T. Thrombopoietin in patients with hepatoblastoma. Stem cells (Dayton, Ohio) 1998; 16: 329–33.
- Shafford EA, Pritchard J. Extreme thrombocytosis as a diagnostic clue to hepatoblastoma. Arch Dis Child 1993; 69: 171.
- De Ioris M, Brugieres L, Zimmermann A, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer 2008; 44: 545–50.
- Roebuck DJ, Olsen O, Pariente D. Radiological staging in children with hepatoblastoma. Pediatr Radiol 2006; 36: 176–82.
- Sato M, Ishida H, Konno K, Naganuma H, et al. Liver tumors in children and young patients: sonographic and color Doppler fi ndings. Abdom Imaging 2000; 25: 596–601.
- Roebuck DJ, Olsen O, Pariente D. Radiological staging in children with hepatoblastoma. Pediatr Radiol 2006; 36: 176–82.
- Archer D, Babyn P, Gilday D, Greenberg MA. Potentially misleading bone scan findings in patients with hepatoblastoma. Clin Nuclear Med 1993; 18: 1026–31.
- Kairemo KJ, Lindahl H, Merenmies J, et al. Anti-alpha-fetoprotein imaging is useful for staging hepatoblastoma. Transplantation 2002; 73: 1151–4.
- Philip I, Shun A, McCowage G, Howman-Giles R. Positron emission tomography in recurrent hepatoblastoma. Pediatr Surg Int 2005; 21: 341–5.
- Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007; 37: 123–32; quiz 249–50.
- Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005; 23: 1245–52.
- Ortega JA, Krailo MD, Haas JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol 1991; 9: 2167–76.
- Douglass EC, Reynolds M, Finegold M, Cantor AB, Glicksman A. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J Clin Oncol 1993; 11: 96–9.
- Anthony P. Tumours and tumour-like lesions of the liver and biliary tract: aetiology, epidemiology and pathology. In: MacSween RNM, Portman BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the Liver, 4th edn. London: Churchill Livingstone; 2002: 711–825.
- Stocker J, Conran R. Hepatoblastoma. In: Okuda K, Tabor E, eds. Liver Cancer. New York: Churchill Livingstone, 1997: 263–78.
-
Haas JE, Muczynski KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989; 64: 1082–95.
10.1002/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
- von Schweinitz D. Management of liver tumors in childhood. Semin Pediatr Surg 2006; 15: 17–24.
- Fuchs J, Rydzynski J, Von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002; 95: 172–82.
- Von Schweinitz D. Treatment of liver tumors in children. In: Clavien P-A, Fong Y, eds. Malignant Liver Tumors: Current and Emerging Therapies. Sudbury, MA: Jones and Bartlett, 2004: 409–26.
- Czauderna P, Otte JB, Roebuck DJ, von Schweinitz D, Plaschkes J. Surgical treatment of hepatoblastoma in children. Pediatr Radiol 2006; 36: 187–91.
- von Schweinitz D, Haeberle B, Fuchs J. Is clinical diagnosis sufficient for beginning of therapy in hepatoblastoma? (abstract). Med Pediatr Oncol 2003; 41: 268.
- Fuchs J, Rydzynski J, Hecker H, et al. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma–a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. Eur J Pediatr Surg 2002; 12: 255–61.
-
Zografos GN, Kakaviatos ND, Skiathitis S, Habib N. Total vascular exclusion for liver resections: pros and cons. J Surg Oncol 1999; 72: 50–5; discussion 55–6.
10.1002/(SICI)1096-9098(199909)72:1<50::AID-JSO14>3.0.CO;2-A CAS PubMed Web of Science® Google Scholar
- Superina RA, Bambini D, Filler RM, Almond PS, Geissler G. A new technique for resecting “unresectable” liver tumors. J Pediatr Surg 2000; 35: 1294–9.
- Otte JB PJ, Aronson DC, Brown J, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004; 42: 74–83.
- Stringer MD. The role of liver transplantation in the management of paediatric liver tumours. Ann R Coll Surg Engl 2007; 89: 12–21.
- Chardot C, Saint Martin C, Gilles A, et al. Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma. Transplantation 2002; 73: 90–2.
- Douglass EC, Green AA, Wrenn E, Champion J, Shipp M, Pratt CB. Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 1985; 13: 187–90.
-
Evans A, Land V, Newton W. Combination chemotherapy (vincristine, adriamycine, cyclophosphamide, and 5-fl uorouracil) in the treatment of children with malignant hepatoma. Cancer 1982; 50: 821–6.
10.1002/1097-0142(19820901)50:5<821::AID-CNCR2820500502>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- Schnater JM, Kuijper CF, Zsiros J, Heij HA, Aronson DC. Preoperative diagnostic biopsy and surgery in paediatric liver tumours–the Amsterdam experience. Eur J Surg Oncol 2005; 31: 1160–5.
- Reynolds M, Douglass EC, Finegold M, Cantor A, Glicksman A. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992; 27: 1080–3; discussion 1083–4.
-
Weinblatt ME, Siegel SE, Siegel MM, Stanley P, Weitzman JJ. Preoperative chemotherapy for unresectable primary hepatic malignancies in children. Cancer 1982; 50: 1061–4.
10.1002/1097-0142(19820915)50:6<1061::AID-CNCR2820500607>3.0.CO;2-Q CAS PubMed Web of Science® Google Scholar
- Filler RM, Ehrlich PF, Greenberg ML, Babyn PS. Preoperative chemotherapy in hepatoblastoma. Surgery 1991; 110: 591–6; discussion 596–7.
- Pritchard J, Mackinlay G, Stringer M. Improved survival outcome for hepatoblastoma. J Pediatr Surg 2004; 39: 1743–4; author reply 1744.
- Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology–SIOPEL 2. Eur J Cancer 2004; 40: 411–21.
- Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey–1974. J Pediatr Surg 1975; 10: 329–37.
- Habrand JL, Nehme D, Kalifa C, et al. Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children? Int J Radiat Oncol Biol Physics 1992; 23: 525–31.
- Czauderna P, Zbrzezniak G, Narozanski W, Korzon M, Wyszomirska M, Stoba C. Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children. Pediatr Blood Cancer 2006; 46: 825–8.
- Hata Y, Takada N, Sasaki F, et al. Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents. J Pediatr Surg 1992; 27: 724–7.
- Mizejewski GJ. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy. Expert Rev Anticancer Ther 2002; 2: 709–35.
- Kairemo KJ, Lindahl H, Merenmies J, et al. Anti-alpha-fetoprotein imaging is useful for staging hepatoblastoma. Transplantation 2002; 73: 1151–4.
- Matsusaka S, Nakasho K, Terada N, et al. Inhibition by an angiogenesis inhibitor, TNP-470, of the growth of a human hepatoblastoma heterotransplanted into nude mice. J Pediatr Surg 2000; 35: 1198–204.
- McCrudden KW, Hopkins B, Frischer J, et al. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis. J Pediatr Surg 2003; 38: 308–14; discussion 308–14.
- Browne M, Stellmach V, Cornwell M, et al. Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model. Pediatr Res 2006; 60: 282–7.
- Davies JQ, de la Hall PM, Kaschula RO, et al. Hepatoblastoma – evolution of management and outcome and signifi cance of histology of the resected tumor. A 31-year experience with 40 cases. J Pediatr Surg 2004; 39: 1321–7.
-
von Schweinitz D, Hecker H, Schmidt-von-Arndt G, Harms D. Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer 1997; 74: 593–9.
10.1002/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- Brown J PG, Shafford E, Keeling J, et al. Pretreatment prognostic factors for children with hepatoblastoma–results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000; 36: 1418–25.
- Van Tornout JM, Buckley JD, Quinn JJ, et al. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. J Clin Oncol 1997; 15: 1190–7.
- Zerbini MC, Sredni ST, Grier H, et al. Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression. Pediatr Dev Pathol 1998; 1: 270–80.
- Weber RG, Pietsch T, von Schweinitz D, Lichter P. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 2000; 157: 571–8.
- Mullarkey M, Breen CJ, McDermott M, O'Meara A, Stallings RL. Genetic abnormalities in a pre and post-chemotherapy hepatoblastoma. Cytogenet Cell Genet 2001; 95: 9–11.
- Exelby PR, Filler RM, Grossfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey–1974. J Pediatr Surg 1975; 10: 329–37.
-
Ni YH, Chang MH, Hsy HY, et al. Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis. Cancer 1991; 68: 1737–41.
10.1002/1097-0142(19911015)68:8<1737::AID-CNCR2820680815>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
-
Haas JE, Muczynski KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989; 64: 1082–95.
10.1002/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
-
Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinicopathologic features. Cancer 1980; 46: 372–9.
10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- Teitelbaum DH, Tuttle S, Carey LC, et al. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg 1985; 202: 36–41.
- Soreide O, Czerniak A, Bradpiece H, et al. Characteristics of fibrolamellar hepatocellular carcinoma: a study of nine cases and a review of the literature. Am J Surg 1986; 151: 518–23.
- El-Sarg HB, Davilla JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 2004; 39: 798–803.
- Chen WJ, Lee JC, Hung WT. Primary malignant tumor of liver in infants and children in Taiwan. J Pediatr Surg 1988; 3: 457–61.
- Moore SW, Hesseling PB, Wessels G, et al. Hepatocellular carcinoma in children. Pediatr Surg Int 1997; 12: 266–70.
- Seung-Beom Y, Hyung-Young K, Hong EO, et al. Clinical characteristics and prognosis of pediatric hepatocellular carcinoma. World J Surg 2006; 30: 43–50.
- Czauderna P, Mackinlay G, Perilongo G, et al. Hepatocellular carcinoma in children: results of the first prospective trial of the International Society of Pediatric Oncology group. J Clin Oncol 2002; 20: 2798–804.
- Chen JC, Chen CC, Chen WJ, et al. Hepatocellular carcinoma in children: clinical review and comparison with adult cases. J Pediatr Surg 1998; 33: 1350–4.
- Katzenstein HM, Krallo MD, Malogolowkin MH, et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group Intergroup study. J Clin Oncol 2002; 20: 2789–97.
- Otte JB, Aronson D, Vraux H, et al. Preoperative chemotherapy, major liver resection and transplantation for primary liver malignancies in children. Transplant Proc 1996; 28: 2393–4.
- Beaunoyer M, Vanatta JM, Ogihara M, et al. Outcomes of transplantation in children with primary hepatic malignancy. Pediatr Transplant 2007; 11: 655–60.
- Austin MT, Leys CM, Feurer ID, et al. Liver transplantation in childhood malignancy: a review of the United Network of Organ Sharing (UNOS) database. J Pediatr Surg 2006; 41: 182–6.
- Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1855–9.
- von Schweinitz D, Glueer S, Mildenberger H. Liver tumors in neonates and very young infants: Diagnostic pitfalls and therapeutic problems. Eur J Pediatr Surg 1995; 5: 72–6.
- Becker JM, Heitler MS. Hepatic hemangioendotheliomas in infancy. Surg Gynecol Obstet 1989; 168: 189–200.
- Choi HY, Lee SJ. Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy. J Korean Med Sci 2001; 16: 127–9.
- Deb G, Donfrancesco A, Ilari I, et al. Hemangioendothelioma: successfull therapy with interferon alpha: a study in association with the Italian Pediatric Hematology/Oncology Society (AIEOP). Med Pediatr Oncol 2002; 38: 118–19.
- Warman S, Bertram H, Kardoff R, Sasse M. Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg 2003; 38: 1177–81.
- Daller JA, Bueno J, Gutierrez J, et al. Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg 1999; 34: 98–106.
- Kasahara M, Kiuchi T, Haga H, et al. Monosegmental living donor liver transplantation for infantile hepatic hemangioendothelioma. J Pediatr Surg 2003; 38: 1108–11.
- Awan S, Davenport M, Portmann B, et al. Angiosarcoma of the liver in children. J Pediatr Surg 1996; 31: 1729–32.
- Dimashkieh HH, Mo JQ, Wyatt-Ashmead J, et al. Pediatric hepatic angiosarcoma: case report and review of the literature. Pediatr Dev Pathol 2004; 7: 527–32.
- Bisogno G, Pilz T, Perilongo G, et al. Undifferentiated sarcoma of the liver in childhood: a curable disiease. Cancer 2002; 94: 252–7.
- Lack EE, Schloo BL, Azumi N, et al. Undifferentiated (embryonal) angiosarcoma of the liver. Clinical and pathological study of 16 cases with emphasis on immunohistological features. Am J Surg Pathol 1991; 15: 1–16.
-
Davis GL, Kissane JM, Ishak KG. Embryonal rhabdomyosarcoma (sarcoma botryoides) of the biliary tree. Cancer 1969; 24: 333–42.
10.1002/1097-0142(196908)24:2<333::AID-CNCR2820240216>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
-
Rhabdomyosarcoma of the biliary tree in childhood: a report from the Intergroup Rhabdomyosarcoma Study. Cancer 1985; 56: 575–81.
10.1002/1097-0142(19850801)56:3<575::AID-CNCR2820560326>3.0.CO;2-9 PubMed Web of Science® Google Scholar
